Current perspectives on prevention of vascular cognitive impairment and promotion of vascular brain health

References

• Karami N, Kazeminia M, Karami A, et al. Global prevalence of depression, anxiety, and stress in cardiac patients: a systematic review and meta-analysis. J Affective Disorders. 2023;324:175–189. doi:10.1016/j.jad.2022.12.055
   PubMed Web of Science ®Google Scholar
• Warriach ZI, Patel S, Khan F, et al. Association of depression with cardiovascular diseases. Cureus. 2022;14(6):e26296. doi:10.7759/cureus.26296
   PubMed Web of Science ®Google Scholar
• Goldfarb M, De Hert M, Detraux J, et al. Severe mental illness and cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol. 2022;80(9):918–933. doi: 10.1016/j.jacc.2022.06.017
   PubMed Web of Science ®Google Scholar
• Arnaud AM, Brister TS, Duckworth K, et al. Impact of major depressive disorder on comorbidities: a systematic literature review. J Clin Psychiatry. 2022;83(6). doi: 10.4088/JCP.21r14328
   PubMed Web of Science ®Google Scholar
• Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42(9):2672–2713. doi: 10.1161/STR.0b013e3182299496
   PubMed Web of Science ®Google Scholar
• Akinyemi RO, Mukaetova-Ladinska EB, Attems J, et al. Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer’s disease and vascular dementia. Curr Alzheimer Res. 2013;10(6):642–653. doi:10.2174/15672050113109990037
   PubMed Web of Science ®Google Scholar
• Howlett SE, Rockwood K. Ageing: develop models of frailty. Nature. 2014;512(7514):253. doi:10.1038/512253d
   PubMed Web of Science ®Google Scholar
• Rockwood K, Theou O, Mitnitski A. What are frailty instruments for? Age Ageing. 2015;44(4):545–547. doi:10.1093/ageing/afv043
   PubMed Web of Science ®Google Scholar
• Wang X, Carcel C, Woodward M, et al. Blood pressure and stroke: a review of sex- and Ethnic/Racial-specific attributes to the epidemiology, pathophysiology, and management of raised blood pressure. Stroke. 2022;53(4):1114–1133. doi:10.1161/STROKEAHA.121.035852
   PubMed Web of Science ®Google Scholar
• O’Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol. 2003;2(2):89–98. doi: 10.1016/S1474-4422(03)00305-3
   PubMed Web of Science ®Google Scholar
• Hachinski V, Iadecola C, Petersen RC, et al. National Institute of neurological disorders and stroke–Canadian stroke network vascular cognitive impairment harmonization standards. Stroke. 2006;37(9):2220–2241. doi: 10.1161/01.STR.0000237236.88823.47
   PubMed Web of Science ®Google Scholar
• Sachdev P. Vascular cognitive disorder. Int J Geriat Psychiatry. 1999;14(5):402–403. doi:10.1002/(SICI)1099-1166(199905)14:5<402:AID-GPS958>3.0.CO;2-H
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association D, Association AP. Diagnostic and statistical manual of mental disorders: DSM-5. Washington, DC: American psychiatric association; 2013. p. 591–644. doi: 10.1176/appi.books.9780890425596
   Google Scholar
• Sachdev P, Kalaria R, O’Brien J, et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;28(3):206–218. doi: 10.1097/WAD.0000000000000034
   PubMed Web of Science ®Google Scholar
• Skrobot OA, O’Brien J, Black S, et al. The vascular impairment of cognition classification consensus study. Alzheimer’s Dementia. 2017;13(6):624–633. doi: 10.1016/j.jalz.2016.10.007
   PubMed Web of Science ®Google Scholar
• Skrobot OA, Black SE, Chen C, et al. Progress toward standardized diagnosis of vascular cognitive impairment: guidelines from the vascular impairment of cognition classification consensus study. Alzheimer’s Dementia. 2018;14(3):280–292. doi: 10.1016/j.jalz.2017.09.007
   PubMed Web of Science ®Google Scholar
• Sachdev PS, Lipnicki DM, Crawford JD, et al. The vascular behavioral and cognitive disorders criteria for vascular cognitive disorders: a validation study. Eur J Neurol. 2019;26(9):1161–1167. doi:10.1111/ene.13960
   PubMed Web of Science ®Google Scholar
• Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International workshop. Neurology. 1993;43(2):250–260. doi: 10.1212/WNL.43.2.250
   PubMed Web of Science ®Google Scholar
• Akinyemi RO, Owolabi MO, Ihara M, et al. Stroke, cerebrovascular diseases and vascular cognitive impairment in Africa. Brain Res Bull. 2019;145:97–108. doi: 10.1016/j.brainresbull.2018.05.018
   PubMed Web of Science ®Google Scholar
• Lam BYK, Cai Y, Akinyemi R, et al. The global burden of cerebral small vessel disease in low- and middle-income countries: a systematic review and meta-analysis. Int J Stroke. 2023;18(1):15–27. doi: 10.1177/17474930221137019
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18(7):684–696. doi:10.1016/S1474-4422(19)30079-1
   PubMed Web of Science ®Google Scholar
• Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701. doi: 10.1016/S1474-4422(10)70104-6
   PubMed Web of Science ®Google Scholar
• Mijajlovic MD, Pavlovic A, Brainin M, et al. Post-stroke dementia – a comprehensive review. BMC Med. 2017;15(1):11. doi: 10.1186/s12916-017-0779-7
   PubMedGoogle Scholar
• Leys D, Hénon H, Mackowiak-Cordoliani M-A, et al. Poststroke dementia. Lancet Neurol. 2005;4(11):752–759. doi:10.1016/S1474-4422(05)70221-0
   PubMed Web of Science ®Google Scholar
• Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8(11):1006–1018. doi:10.1016/S1474-4422(09)70236-4
   PubMed Web of Science ®Google Scholar
• Pendlebury ST, Rothwell PM, Oxford Vascular S. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford vascular study. Lancet Neurol. 2019;18(3):248–258. doi:10.1016/S1474-4422(18)30442-3
   PubMed Web of Science ®Google Scholar
• Craig L, Hoo ZL, Yan TZ, et al. Prevalence of dementia in ischaemic or mixed stroke populations: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2022;93(2):180–187. doi:10.1136/jnnp-2020-325796
   PubMedGoogle Scholar
• Allan LM, Rowan EN, Firbank MJ, et al. Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain. 2012;134(Pt 12):3716–3727. doi: 10.1093/brain/awr273
   Google Scholar
• Bejot Y, Aboa-Eboule C, Durier J, et al. Prevalence of early dementia after first-ever stroke: a 24-year population-based study. Stroke. 2011;42(3):607–612. doi: 10.1161/STROKEAHA.110.595553
   PubMed Web of Science ®Google Scholar
• Pohjasvaara T, Erkinjuntti T, Vataja R, et al. Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the helsinki stroke aging memory study (SAM) cohort. Stroke. 1997;28(4):785–792. doi:10.1161/01.STR.28.4.785
   PubMed Web of Science ®Google Scholar
• Thomas AJ, Kalaria RN, O’Brien JT. Depression and vascular disease: what is the relationship? J Affective Disorders. 2004;79(1–3):81–95. doi:10.1016/S0165-0327(02)00349-X
   PubMed Web of Science ®Google Scholar
• Allan LM, Rowan EN, Thomas AJ, et al. Long-term incidence of depression and predictors of depressive symptoms in older stroke survivors. Br J Psychiatry. 2013;203(6):453–460. doi:10.1192/bjp.bp.113.128355
   PubMed Web of Science ®Google Scholar
• Bella R, Ferri R, Cantone M, et al. Motor cortex excitability in vascular depression. Int J Psychophysiol. 2011;82(3):248–253. doi: 10.1016/j.ijpsycho.2011.09.006
   PubMed Web of Science ®Google Scholar
• Polvikoski TM, van Straaten EC, Barkhof F, et al. Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old. Neurology. 2010;75(23):2071–2078. doi: 10.1212/WNL.0b013e318200d6f9
   PubMed Web of Science ®Google Scholar
• Zekry D, Duyckaerts C, Moulias R, et al. Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly. Acta Neuropathol. 2002;103(5):481–487. doi: 10.1007/s00401-001-0493-5
   PubMed Web of Science ®Google Scholar
• Schneider JA, Wilson RS, Bienias JL, et al. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology. 2004;62(7):1148–1155. doi:10.1212/01.WNL.0000118211.78503.F5
   PubMed Web of Science ®Google Scholar
• Kalaria RN, Kenny RA, Ballard CG, et al. Towards defining the neuropathological substrates of vascular dementia. J Neurolog Sci. 2004;226(1–2):75–80. doi:10.1016/j.jns.2004.09.019
   PubMed Web of Science ®Google Scholar
• Kalaria RN, Ihara M. Medial temporal lobe atrophy is the norm in cerebrovascular dementias. Eur J Neurol. 2017;24(4):539–540. doi:10.1111/ene.13243
   PubMed Web of Science ®Google Scholar
• Collaborators GBDS, Stark BA, Johnson CO. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol. 2021;20(10):795–820. doi: 10.1016/S1474-4422(21)00252-0
   PubMed Web of Science ®Google Scholar
• Ding Q, Liu S, Yao Y, et al. Global, regional, and National burden of ischemic stroke, 1990–2019. Neurology. 2022;98(3):e279–e290. doi:10.1212/WNL.0000000000013115
   PubMed Web of Science ®Google Scholar
• Collaborators GBDD. The burden of dementia due to down syndrome, Parkinson’s disease, stroke, and traumatic brain injury: a systematic analysis for the global burden of disease study 2019. Neuroepidemiology. 2021;55(4):286–296
   PubMed Web of Science ®Google Scholar
• Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021. doi: 10.1016/j.jacc.2020.11.010
   PubMed Web of Science ®Google Scholar
• Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, et al. Geographic distribution of metabolic syndrome and its components in the general adult population: a meta-analysis of global data from 28 million individuals. Diabet Res Clin Pract. 2022;188:109924. doi: 10.1016/j.diabres.2022.109924
   PubMed Web of Science ®Google Scholar
• Exalto LG, Weaver NA, Kuijf HJ, et al. Sex differences in Poststroke cognitive impairment: a multicenter study in 2343 patients with acute ischemic stroke. Stroke. 2023;54(9):2296–2303. doi: 10.1161/STROKEAHA.123.042507
   PubMed Web of Science ®Google Scholar
• Cantone M, Fisicaro F, Ferri R, et al. Sex differences in mild vascular cognitive impairment: a multimodal transcranial magnetic stimulation study. PLoS One. 2023;18(3):e0282751. doi: 10.1371/journal.pone.0282751
   PubMed Web of Science ®Google Scholar
• Bryan RN, Cai J, Burke G, et al. Prevalence and anatomic characteristics of infarct-like lesions on MR images of middle-aged adults: the atherosclerosis risk in communities study. AJNR Am J Neuroradiol. 1999;20(7):1273–1280.
   PubMed Web of Science ®Google Scholar
• Inzitari D, Pracucci G, Poggesi A, et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ. 2009;339(jul06 1):b2477. doi: 10.1136/bmj.b2477
   PubMedGoogle Scholar
• Del Brutto OH, Mera RM, Cagino K, et al. Neuroimaging signatures of frailty: a population-based study in community-dwelling older adults (the atahualpa project). Geriatrics Gerontol Int. 2016;17(2):270–276. doi: 10.1111/ggi.12708
   PubMed Web of Science ®Google Scholar
• Jochems ACC, Arteaga C, Chappell F, et al. Longitudinal changes of white matter hyperintensities in sporadic small vessel disease: a systematic review and meta-analysis. Neurology. 2022;99(22):e2454–e2463. doi: 10.1212/WNL.0000000000201205
   PubMed Web of Science ®Google Scholar
• Zhang F, Ping Y, Jin X, et al. White matter hyperintensities and post-stroke depression: a systematic review and meta-analysis. J Affective Disorders. 2023;320:370–380. doi:10.1016/j.jad.2022.09.166
   PubMed Web of Science ®Google Scholar
• Howard DPJ, Gaziano L, Rothwell PM, et al. Risk of stroke in relation to degree of asymptomatic carotid stenosis: a population-based cohort study, systematic review, and meta-analysis. Lancet Neurol. 2021;20(3):193–202. doi:10.1016/S1474-4422(20)30484-1
   PubMed Web of Science ®Google Scholar
• Lazar RM, Wadley VG, Myers T, et al. Baseline cognitive impairment in patients with asymptomatic carotid stenosis in the CREST-2 trial. Stroke. 2021;52(12):3855–3863. doi: 10.1161/STROKEAHA.120.032972
   PubMed Web of Science ®Google Scholar
• Blevins BL, Vinters HV, Love S, et al. Brain arteriolosclerosis. Acta Neuropathol. 2021;141(1):1–24. doi: 10.1007/s00401-020-02235-6
   PubMed Web of Science ®Google Scholar
• Kalaria RN, Hase Y. Neurovascular Ageing and age-related diseases. Subcell Biochem. 2019;91:477–499.
   PubMedGoogle Scholar
• Molnar AA, Nadasy GL, Dornyei G, et al. The aging venous system: from varicosities to vascular cognitive impairment. Geroscience. 2021;43(6):2761–2784. doi: 10.1007/s11357-021-00475-2
   PubMed Web of Science ®Google Scholar
• Kapadia A, Dmytriw AA. Venous dysfunction plays a critical role in “normal” white matter disease of aging. Med Hypotheses. 2021;146:110457. doi:10.1016/j.mehy.2020.110457
   PubMed Web of Science ®Google Scholar
• Carare RO, Aldea R, Agarwal N, et al. Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of vascular professional interest area (PIA): cerebrovascular disease and the failure of elimination of amyloid-beta from the brain and retina with age and Alzheimer’s disease-opportunities for therapy. Alzheimer’s Dementia. 2020;12(1):e12053.
   Web of Science ®Google Scholar
• Poh L, Sim WL, Jo DG, et al. The role of inflammasomes in vascular cognitive impairment. Mol Neurodegener. 2022;17(1):4. doi: 10.1186/s13024-021-00506-8
   PubMed Web of Science ®Google Scholar
• Custodero C, Ciavarella A, Panza F, et al. Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis. Geroscience. 2022;44(3):1373–1392. doi: 10.1007/s11357-022-00556-w
   PubMed Web of Science ®Google Scholar
• Skrobot OA, McKnight AJ, Passmore PA, et al. A validation study of vascular cognitive impairment genetics meta-analysis findings in an independent collaborative cohort. J Alzheimer’s Disease: JAD. 2016;53(3):981–989. doi: 10.3233/JAD-150862
   PubMed Web of Science ®Google Scholar
• Ballard CG, Morris CM, Rao H, et al. APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment. Neurology. 2004;63(8):1399–1402. doi: 10.1212/01.WNL.0000141851.93193.17
   PubMed Web of Science ®Google Scholar
• Kalaria RN, Kittner SJ. Top-NOTCH3 variants in the population at large. Stroke. 2020;51(12):3482–3484. doi:10.1161/STROKEAHA.120.031609
   PubMed Web of Science ®Google Scholar
• Cho BPH, Harshfield EL, Al-Thani M, et al. Association of vascular risk factors and genetic factors with penetrance of variants causing monogenic stroke. JAMA Neurol. 2022;79(12):1303–1311. doi:10.1001/jamaneurol.2022.3832
   PubMed Web of Science ®Google Scholar
• Rajeev V, Chai YL, Poh L, et al. Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment. Acta Neuropathol Commun. 2023;11(1):93. doi: 10.1186/s40478-023-01590-1
   PubMed Web of Science ®Google Scholar
• Rolandi E, Zaccaria D, Vaccaro R, et al. Estimating the potential for dementia prevention through modifiable risk factors elimination in the real-world setting: a population-based study. Alzheimer’s Res Ther. 2020;12(1):94. doi: 10.1186/s13195-020-00661-y
   PubMed Web of Science ®Google Scholar
• Ingaramo RA. Obesity, diabetes, and other cardiovascular risk factors in native populations of South America. Curr Hypertens Rep. 2016;18(1):9. doi:10.1007/s11906-015-0613-6
   PubMed Web of Science ®Google Scholar
• Noale M, Limongi F, Maggi S. Epidemiology of cardiovascular diseases in the elderly. Adv Exp Med Biol. 2020;1216:29–38.
   PubMed Web of Science ®Google Scholar
• Allan LM, Rowan EN, Firbank MJ, et al. Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain. 2011;134(Pt 12):3716–3727. doi: 10.1093/brain/awr273
   PubMed Web of Science ®Google Scholar
• Afilalo J, Karunananthan S, Eisenberg MJ, et al. Role of frailty in patients with cardiovascular disease. Am J Cardiol. 2009;103(11):1616–1621. doi:10.1016/j.amjcard.2009.01.375
   PubMed Web of Science ®Google Scholar
• Singh M, Stewart R, White H. Importance of frailty in patients with cardiovascular disease. Eur Heart J. 2014;35(26):1726–1731. doi:10.1093/eurheartj/ehu197
   PubMed Web of Science ®Google Scholar
• Gheorghe A, Griffiths U, Murphy A, et al. The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review. BMC Public Health. 2018;18(1):975. doi:10.1186/s12889-018-5806-x
   PubMed Web of Science ®Google Scholar
• Delgado J, Masoli J, Hase Y, et al. Trajectories of cognitive change following stroke: stepwise decline towards dementia in the elderly. Brain Commun. 2022;4(3):fcac129. doi: 10.1093/braincomms/fcac129
   PubMedGoogle Scholar
• McHutchison CA, Backhouse EV, Cvoro V, et al. Education, socioeconomic status, and intelligence in childhood and stroke risk in later life: a meta-analysis. Epidemiology. 2017;28(4):608–618. doi:10.1097/EDE.0000000000000675
   PubMed Web of Science ®Google Scholar
• Sarki AM, Nduka CU, Stranges S, et al. Prevalence of hypertension in low- and middle-income countries: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94(50):e1959. doi:10.1097/MD.0000000000001959
   PubMed Web of Science ®Google Scholar
• Cantone M, Lanza G, Puglisi V, et al. Hypertensive crisis in acute cerebrovascular diseases presenting at the emergency department: a narrative review. Brain Sci. 2021;11(1):70. doi: 10.3390/brainsci11010070
   PubMed Web of Science ®Google Scholar
• Forouzanfar MH, Liu P, Roth GA, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm hg, 1990-2015. JAMA. 2017;317(2):165–182. doi: 10.1001/jama.2016.19043
   PubMed Web of Science ®Google Scholar
• Zhou B, Carrillo-Larco RM, Danaei G, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet. 2021;398(10304):957–980. doi: 10.1016/S0140-6736(21)01330-1
   PubMed Web of Science ®Google Scholar
• Mahinrad S, Sorond FA, Gorelick PB. Hypertension and cognitive dysfunction: a review of mechanisms, life-course observational studies and clinical trial results. Rev Cardiovasc Med. 2021;22(4):1429–1449. doi:10.31083/j.rcm2204148
   PubMed Web of Science ®Google Scholar
• Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet. 2010;375(9718):938–948. doi:10.1016/S0140-6736(10)60309-1
   PubMed Web of Science ®Google Scholar
• de Heus RAA, Tzourio C, Lee EJL, et al. Association between blood pressure variability with dementia and cognitive impairment: a systematic review and meta-analysis. Hypertension. 2021;78(5):1478–1489. doi: 10.1161/HYPERTENSIONAHA.121.17797
   PubMed Web of Science ®Google Scholar
• Jia P, Lee HWY, Chan JYC, et al. Long-term blood pressure variability increases risks of dementia and cognitive decline: a meta-analysis of longitudinal studies. Hypertension. 2021;78(4):996–1004. doi:10.1161/HYPERTENSIONAHA.121.17788
   PubMed Web of Science ®Google Scholar
• Aribisala BS, Morris Z, Eadie E, et al. Blood pressure, internal carotid artery flow parameters, and age-related white matter hyperintensities. Hypertension. 2014;63(5):1011–1018. doi: 10.1161/HYPERTENSIONAHA.113.02735
   PubMed Web of Science ®Google Scholar
• Markus HS, Erik de Leeuw F. Cerebral small vessel disease: recent advances and future directions. Int J Stroke. 2023;18(1):4–14. doi:10.1177/17474930221144911
   PubMed Web of Science ®Google Scholar
• Jiang X, Lewis CE, Allen NB, et al. Premature cardiovascular disease and brain health in midlife: the CARDIA study. Neurology. 2023;100(14):e1454–e1463. doi:10.1212/WNL.0000000000206825
   PubMed Web of Science ®Google Scholar
• Kim WSH, Luciw NJ, Atwi S, et al. Associations of white matter hyperintensities with networks of gray matter blood flow and volume in midlife adults: a coronary artery risk development in young adults magnetic resonance imaging substudy. Human Brain Mapp. 2022;43(12):3680–3693. doi: 10.1002/hbm.25876
   PubMed Web of Science ®Google Scholar
• Affleck AJ, Sachdev PS, Halliday GM. Past antihypertensive medication use is associated with lower levels of small vessel disease and lower Aβ plaque stage in the brains of older individuals. Neuropathol Appl Neurobiol. 2023;49(4):e12922. doi: 10.1111/nan.12922
   PubMed Web of Science ®Google Scholar
• Kayima J, Wanyenze RK, Katamba A, et al. Hypertension awareness, treatment and control in Africa: a systematic review. BMC Cardiovasc Disord. 2013;13(1):54. doi: 10.1186/1471-2261-13-54
   PubMedGoogle Scholar
• Chang-Quan H, Hui W, Chao-Min W, et al. The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies. Int J Clin Pract. 2011;65(12):1295–1305. doi: 10.1111/j.1742-1241.2011.02810.x
   PubMed Web of Science ®Google Scholar
• Levi Marpillat N, Macquin-Mavier I, Tropeano AI, et al. Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. J Hypertens. 2013;31(6):1073–1082. doi:10.1097/HJH.0b013e3283603f53
   PubMed Web of Science ®Google Scholar
• Tully PJ, Hanon O, Cosh S, et al. Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies. J Hypertens. 2016;34(6):1027–1035. doi:10.1097/HJH.0000000000000868
   PubMed Web of Science ®Google Scholar
• Gupta A, Perdomo S, Billinger S, et al. Treatment of hypertension reduces cognitive decline in older adults: a systematic review and meta-analysis. BMJ Open. 2020;10(11):e038971. doi:10.1136/bmjopen-2020-038971
   PubMed Web of Science ®Google Scholar
• Hughes D, Judge C, Murphy R, et al. Association of blood pressure lowering with incident dementia or cognitive impairment: a systematic review and meta-analysis. JAMA. 2020;323(19):1934–1944. doi: 10.1001/jama.2020.4249
   PubMed Web of Science ®Google Scholar
• Ou YN, Tan CC, Shen XN, et al. Blood pressure and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 209 prospective studies. Hypertension. 2020;76(1):217–225. doi: 10.1161/HYPERTENSIONAHA.120.14993
   PubMed Web of Science ®Google Scholar
• Peters R, Yasar S, Anderson CS, et al. Investigation of antihypertensive class, dementia, and cognitive decline: a meta-analysis. Neurology. 2020;94(3):e267–e281. doi: 10.1212/WNL.0000000000008732
   PubMed Web of Science ®Google Scholar
• den Brok M, van Dalen JW, Abdulrahman H, et al. Antihypertensive medication classes and the risk of dementia: a systematic review and network meta-analysis. J Am Med Dir Assoc. 2021;22(7):1386–1395 e1315. doi: 10.1016/j.jamda.2020.12.019
   PubMed Web of Science ®Google Scholar
• Ho JK, Moriarty F, Manly JJ, et al. Blood-brain barrier crossing renin-angiotensin drugs and cognition in the elderly: a meta-analysis. Hypertension. 2021;78(3):629–643. doi: 10.1161/HYPERTENSIONAHA.121.17049
   PubMed Web of Science ®Google Scholar
• Peters R, Xu Y, Fitzgerald O, et al. Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis. Eur Heart J. 2022;43(48):4980–4990. doi: 10.1093/eurheartj/ehac584
   PubMed Web of Science ®Google Scholar
• van Rijssel AE, Stins BC, Beishon LC, et al. Effect of antihypertensive treatment on cerebral blood flow in older adults: a systematic review and meta-analysis. Hypertension. 2022;79(5):1067–1078. doi: 10.1161/HYPERTENSIONAHA.121.18255
   PubMed Web of Science ®Google Scholar
• Dallaire-Theroux C, Quesnel-Olivo MH, Brochu K, et al. Evaluation of intensive vs standard blood pressure reduction and Association with cognitive decline and dementia: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(11):e2134553. doi: 10.1001/jamanetworkopen.2021.34553
   PubMed Web of Science ®Google Scholar
• Cunningham EL, Todd SA, Passmore P, et al. Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia. Cochrane Database Syst Rev. 2021;5(5):CD004034. doi:10.1002/14651858.CD004034.pub4
   PubMedGoogle Scholar
• Jordan F, Quinn TJ, McGuinness B, et al. Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia. Cochrane Database Syst Rev. 2020;4(4):CD011459. doi: 10.1002/14651858.CD011459.pub2
   PubMedGoogle Scholar
• Kwan J, Hafdi M, Chiang LLW, et al. Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia. Cochrane Database Syst Rev. 2022;7(7):CD012269. doi:10.1002/14651858.CD012269.pub2
   PubMedGoogle Scholar
• Ryan J, Storey E, Murray AM, et al. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline. Neurology. 2020;95(3):e320–e331. doi: 10.1212/WNL.0000000000009277
   PubMed Web of Science ®Google Scholar
• Alexander P, Visagan S, Jawhar S, et al. Antiplatelets and vascular dementia: a systematic review. J Aging Res. 2022;2022:9780067. doi: 10.1155/2022/9780067
   PubMedGoogle Scholar
• Wong KS, Wang Y, Leng X, et al. Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis. Circulation. 2013;128(15):1656–1666. doi: 10.1161/CIRCULATIONAHA.113.003187
   PubMed Web of Science ®Google Scholar
• Kim WJ, Noh JH, Han K, et al. The Association between second-line oral antihyperglycemic medication on types of dementia in type 2 diabetes: a nationwide real-world longitudinal study. J Alzheimer’s Disease: JAD. 2021;81(3):1263–1272. doi:10.3233/JAD-201535
   PubMed Web of Science ®Google Scholar
• Dai J, Ports KD, Corrada MM, et al. Metformin and dementia risk: a systematic review with respect to time related Biases. J Alzheimers Dis Rep. 2022;6(1):443–459. doi:10.3233/ADR-220002
   PubMedGoogle Scholar
• Zhang JH, Zhang XY, Sun YQ, et al. Metformin use is associated with a reduced risk of cognitive impairment in adults with diabetes mellitus: a systematic review and meta-analysis. Front Neurosci. 2022;16:984559. doi:10.3389/fnins.2022.984559
   PubMed Web of Science ®Google Scholar
• Kim YG, Jeon J, Kim HJ, et al. Risk of dementia in older patients with type 2 diabetes on dipeptidyl-peptidase IV inhibitors versus sulfonylureas: a real-world population-based cohort study. J Clin Med. 2018;8(1):28. doi: 10.3390/jcm8010028
   PubMed Web of Science ®Google Scholar
• Norgaard CH, Friedrich S, Hansen CT, et al. Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers. Alzheimers Dement (N Y). 2022;8(1):e12268. doi: 10.1002/trc2.12268
   PubMedGoogle Scholar
• Tang H, Shao H, Shaaban CE, et al. Newer glucose-lowering drugs and risk of dementia: a systematic review and meta-analysis of observational studies. J American Geriatrics Society. 2023;71(7):2096–2106. doi: 10.1111/jgs.18306
   PubMed Web of Science ®Google Scholar
• Luan S, Cheng W, Wang C, et al. Impact of glucagon-like peptide 1 analogs on cognitive function among patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol. 2022;13:1047883. doi:10.3389/fendo.2022.1047883
   PubMed Web of Science ®Google Scholar
• Jin Y, Zhao H, Hou Y, et al. The effects of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide 1 receptor agonists on cognitive functions in adults with type 2 diabetes mellitus: a systematic review and meta-analysis. Acta Diabetol. 2020;57(10):1129–1144. doi:10.1007/s00592-020-01529-1
   PubMed Web of Science ®Google Scholar
• Wu CY, Iskander C, Wang C, et al. Association of Sodium–glucose cotransporter 2 inhibitors with time to dementia: a population-based cohort study. Diabetes Care. 2023;46(2):297–304. doi: 10.2337/dc22-1705
   PubMed Web of Science ®Google Scholar
• Yang Z, Wang H, Edwards D, et al. Association of blood lipids, atherosclerosis and statin use with dementia and cognitive impairment after stroke: a systematic review and meta-analysis. Ageing Res Rev. 2020;57:100962. doi: 10.1016/j.arr.2019.100962
   PubMed Web of Science ®Google Scholar
• McGuinness B, Craig D, Bullock R, et al. Statins for the prevention of dementia. Cochrane Database Syst Rev. 2016;2016(1):CD003160. doi:10.1002/14651858.CD003160.pub3
   PubMedGoogle Scholar
• Wardlaw JM, Woodhouse LJ, Mhlanga II, et al. Isosorbide mononitrate and Cilostazol treatment in patients with symptomatic cerebral small vessel disease: the lacunar intervention trial-2 (LACI-2) randomized clinical trial. JAMA Neurol. 2023;80(7):682. doi: 10.1001/jamaneurol.2023.1526
   PubMed Web of Science ®Google Scholar
• Tai SY, Chien CY, Chang YH, et al. Cilostazol use is associated with reduced risk of dementia: a nationwide cohort study. Neurotherapeutics. 2017;14(3):784–791. doi:10.1007/s13311-017-0512-4
   PubMed Web of Science ®Google Scholar
• Pajewski NM, Berlowitz DR, Bress AP, et al. Intensive vs standard blood pressure control in adults 80 years or older: a secondary analysis of the systolic blood pressure intervention trial. J American Geriatrics Society. 2020;68(3):496–504. doi: 10.1111/jgs.16272
   PubMed Web of Science ®Google Scholar
• Gaussoin SA, Pajewski NM, Chelune G, et al. Effect of intensive blood pressure control on subtypes of mild cognitive impairment and risk of progression from SPRINT study. J American Geriatrics Society. 2022;70(5):1384–1393. doi: 10.1111/jgs.17583
   PubMed Web of Science ®Google Scholar
• Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vazquez A, et al. Pathophysiological mechanisms linking type 2 diabetes and dementia: review of evidence from clinical, translational and epidemiological Research. Curr Diabetes Rev. 2019;15(6):456–470. doi:10.2174/1573399815666190129155654
   PubMed Web of Science ®Google Scholar
• Cheng G, Huang C, Deng H, et al. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012;42(5):484–491. doi:10.1111/j.1445-5994.2012.02758.x
   PubMed Web of Science ®Google Scholar
• Antal B, McMahon LP, Sultan SF, et al. Type 2 diabetes mellitus accelerates brain aging and cognitive decline: complementary findings from UK Biobank and meta-analyses. Elife. 2022;11: doi: 10.7554/eLife.73138
   Web of Science ®Google Scholar
• Luchsinger JA, Ryan C, Launer LJ. Diabetes and cognitive impairment. In: Cowie C, Casagrande S, and Menke A, et al. Diabetes in America. 3rd ed. Chapter 24, Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018. PMID: 33651563.
   Google Scholar
• Guan Y, Ebrahimzadeh SA, Cheng CH, et al. Association of diabetes and hypertension with brain structural integrity and cognition in the Boston Puerto Rican health study cohort. Neurology. 2022;98(15):e1534–e1544. doi: 10.1212/WNL.0000000000200120
   PubMed Web of Science ®Google Scholar
• Shi S, Gouskova N, Najafzadeh M, et al. Intensive versus standard blood pressure control in type 2 diabetes: a restricted mean survival time analysis of a randomised controlled trial. BMJ Open. 2021;11(9):e050335. doi:10.1136/bmjopen-2021-050335
   PubMedGoogle Scholar
• Wu CY, Shapiro L, Ouk M, et al. Glucose-lowering drugs, cognition, and dementia: the clinical evidence. Neurosci Biobehav Rev. 2022;137:104654. doi: 10.1016/j.neubiorev.2022.104654
   PubMed Web of Science ®Google Scholar
• Hamal C, Velugoti L, Tabowei G, et al. Metformin for the improvement of comorbid depression symptoms in diabetic patients: a systematic review. Cureus. 2022;14(8):e28609. doi: 10.7759/cureus.28609
   PubMed Web of Science ®Google Scholar
• Sergi D, Zauli E, Tisato V, et al. Lipids at the nexus between cerebrovascular disease and vascular dementia: the impact of HDL-Cholesterol and ceramides. Int J Mol Sci. 2023;24(5):4403. doi: 10.3390/ijms24054403
   PubMed Web of Science ®Google Scholar
• Wee J, Sukudom S, Bhat S, et al. The relationship between midlife dyslipidemia and lifetime incidence of dementia: a systematic review and meta-analysis of cohort studies. Alzheimer’s Dementia. 2023;15(1):e12395. doi: 10.1002/dad2.12395
   Web of Science ®Google Scholar
• Power MC, Rawlings A, Sharrett AR, et al. Association of midlife lipids with 20-year cognitive change: a cohort study. Alzheimer’s Dementia. 2018;14(2):167–177. doi: 10.1016/j.jalz.2017.07.757
   PubMed Web of Science ®Google Scholar
• Seixas AA, Turner AD, Bubu OM, et al. Obesity and race may explain differential burden of white matter hyperintensity load. Clin Interventions Aging. 2021;16:1563–1571. doi: 10.2147/CIA.S316064
   PubMed Web of Science ®Google Scholar
• Yu J, Morys F, Dagher A, et al. Associations between sleep-related symptoms, obesity, cardiometabolic conditions, brain structural alterations and cognition in the UK biobank. Sleep Med. 2023;103:41–50. doi: 10.1016/j.sleep.2023.01.023
   PubMed Web of Science ®Google Scholar
• Ishii M, Iadecola C. Adipocyte-derived factors in age-related dementia and their contribution to vascular and Alzheimer pathology. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2016;1862(5):966–974. doi:10.1016/j.bbadis.2015.10.029
   PubMed Web of Science ®Google Scholar
• Anjum I, Fayyaz M, Wajid A, et al. Does obesity increase the risk of dementia: a literature review. Cureus. 2018;10(5):e2660. doi:10.7759/cureus.2660
   PubMed Web of Science ®Google Scholar
• Erickson LD, Gale SD, Anderson JE, et al. Association between exposure to air pollution and total gray matter and total white matter volumes in adults: a cross-sectional study. Brain Sci. 2020;10(3):164. doi: 10.3390/brainsci10030164
   PubMed Web of Science ®Google Scholar
• Delgado-Saborit JM, Guercio V, Gowers AM, et al. A critical review of the epidemiological evidence of effects of air pollution on dementia, cognitive function and cognitive decline in adult population. Sci Total Environ. 2021;757:143734. doi:10.1016/j.scitotenv.2020.143734
   PubMed Web of Science ®Google Scholar
• Shaffer RM, Sheppard L, Peskind ER, et al. Fine particulate matter exposure and cerebrospinal fluid markers of vascular injury. J Alzheimer’s Disease: JAD. 2019;71(3):1015–1025. doi:10.3233/JAD-190563
   PubMed Web of Science ®Google Scholar
• Perales-Puchalt J, Vidoni ML, Llibre Rodriguez J, et al. Cardiovascular health and dementia incidence among older adults in Latin America: results from the 10/66 study. Int J Geriat Psychiatry. 2019;34(7):1041–1049. doi: 10.1002/gps.5107
   PubMed Web of Science ®Google Scholar
• Fernandes BFS, Caramelli P. Ischemic stroke and infectious diseases in low-income and middle-income countries. Curr Opin Neurol. 2019;32(1):43–48. doi:10.1097/WCO.0000000000000641
   PubMed Web of Science ®Google Scholar
• Obi IE, McPherson KC, Pollock JS. Childhood adversity and mechanistic links to hypertension risk in adulthood. Br J Pharmacol. 2019;176(12):1932–1950. doi:10.1111/bph.14576
   PubMed Web of Science ®Google Scholar
• Godoy LC, Frankfurter C, Cooper M, et al. Association of adverse childhood experiences with cardiovascular disease later in life: a review. JAMA Cardiol. 2021;6(2):228–235. doi:10.1001/jamacardio.2020.6050
   PubMed Web of Science ®Google Scholar
• Seligowski AV, Webber TK, Marvar PJ, et al. Involvement of the brain–heart axis in the link between PTSD and cardiovascular disease. Depress Anxiety. 2022;39(10–11):663–674. doi:10.1002/da.23271
   PubMed Web of Science ®Google Scholar
• Dawson J, Bejot Y, Christensen LM, et al. European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack. Eur Stroke J. 2022;7(3):I–XLI. doi: 10.1177/23969873221100032
   Web of Science ®Google Scholar
• van den Brink AC, Brouwer-Brolsma EM, Berendsen AAM, et al. The Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean-DASH intervention for neurodegenerative delay (MIND) diets are associated with less cognitive decline and a lower risk of Alzheimer’s disease—a review. Adv Nutr. 2019;10(6):1040–1065. doi:10.1093/advances/nmz054
   PubMed Web of Science ®Google Scholar
• Andrews V, Zammit G, O’Leary F. Dietary pattern, food, and nutritional supplement effects on cognitive outcomes in mild cognitive impairment: a systematic review of previous reviews. Nutr Rev. 2023;81(11):1462–1489. doi: 10.1093/nutrit/nuad013
   PubMed Web of Science ®Google Scholar
• Malek Rivan NF, Shahar S, Fakhruddin N, et al. The effect of dietary patterns on mild cognitive impairment and dementia incidence among community-dwelling older adults. Front Nutr. 2022;9:901750. doi:10.3389/fnut.2022.901750
   PubMed Web of Science ®Google Scholar
• Chen H, Dhana K, Huang Y, et al. Association of the mediterranean dietary approaches to stop hypertension intervention for neurodegenerative delay (MIND) diet with the risk of dementia. JAMA Psychiatry. 2023;80(6):630–638. doi: 10.1001/jamapsychiatry.2023.0800
   PubMed Web of Science ®Google Scholar
• Gil Martinez V, Avedillo Salas A, Santander Ballestin S. Vitamin supplementation and dementia: a systematic review. Nutrients. 2022;14(5):1033. doi: 10.3390/nu14051033
   PubMed Web of Science ®Google Scholar
• Bonyadi N, Dolatkhah N, Salekzamani Y, et al. Effect of berry-based supplements and foods on cognitive function: a systematic review. Sci Rep. 2022;12(1):3239. doi:10.1038/s41598-022-07302-4
   PubMed Web of Science ®Google Scholar
• Bermejo PE, Dorado R, Zea-Sevilla MA. Role of Citicoline in patients with mild cognitive impairment. J Exp Neurosci. 2023;18:26331055231152496. doi:10.1177/26331055231152496
   Google Scholar
• Davinelli S, Ali S, Solfrizzi V, et al. Carotenoids and cognitive outcomes: a meta-analysis of randomized intervention trials. Antioxidants. 2021;10(2):223. doi: 10.3390/antiox10020223
   Web of Science ®Google Scholar
• Iso-Markku P, Kujala UM, Knittle K, et al. Physical activity as a protective factor for dementia and Alzheimer’s disease: systematic review, meta-analysis and quality assessment of cohort and case–control studies. Br J Sports Med. 2022;56(12):701–709. doi:10.1136/bjsports-2021-104981
   PubMed Web of Science ®Google Scholar
• Balbim GM, Falck RS, Barha CK, et al. Effects of exercise training on the cognitive function of older adults with different types of dementia: a systematic review and meta-analysis. Br J Sports Med. 2022;56(16):933–940. doi: 10.1136/bjsports-2021-104955
   Web of Science ®Google Scholar
• Yan J, Li X, Guo X, et al. Effect of multicomponent exercise on cognition, physical function and activities of daily life in older adults with dementia or mild cognitive impairment: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2023. doi:10.1016/j.apmr.2023.04.011.
   Web of Science ®Google Scholar
• Rivas-Campo Y, Garcia-Garro PA, Aibar-Almazan A, et al. The effects of high-intensity functional training on cognition in older adults with cognitive impairment: a systematic review. Healthcare. 2022;10(4):670. doi: 10.3390/healthcare10040670
   Web of Science ®Google Scholar
• Liu L, Dong H, Jin X, et al. Tackling dementia: a systematic review of interventions based on physical activity. J Geriatr Phys Ther. 2022;45(4):E169–E180. doi:10.1519/JPT.0000000000000332
   PubMed Web of Science ®Google Scholar
• Xu W, Wang HF, Wan Y, et al. Leisure time physical activity and dementia risk: a dose-response meta-analysis of prospective studies. BMJ Open. 2017;7(10):e014706. doi:10.1136/bmjopen-2016-014706
   PubMed Web of Science ®Google Scholar
• Venegas-Sanabria LC, Cavero-Redondo I, Martinez-Vizcaino V, et al. Effect of multicomponent exercise in cognitive impairment: a systematic review and meta-analysis. BMC Geriatr. 2022;22(1):617. doi:10.1186/s12877-022-03302-1
   PubMed Web of Science ®Google Scholar
• Kivipelto M, Mangialasche F, Ngandu T. Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Nat Rev Neurol. 2018;14(11):653–666. doi:10.1038/s41582-018-0070-3
   PubMed Web of Science ®Google Scholar
• Gomez-Soria I, Marin-Puyalto J, Peralta-Marrupe P, et al. Effects of multi-component non-pharmacological interventions on cognition in participants with mild cognitive impairment: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2022;103:104751. doi:10.1016/j.archger.2022.104751
   PubMed Web of Science ®Google Scholar
• Kumagai R, Osaki T, Oki Y, et al. The Japan-multimodal intervention trial for prevention of dementia PRIME Tamba (J-MINT PRIME Tamba): study protocol of a randomised controlled multi-domain intervention trial. Arch Gerontol Geriatr. 2023;104:104803. doi: 10.1016/j.archger.2022.104803
   PubMed Web of Science ®Google Scholar
• Solomon A, Stephen R, Altomare D, et al. Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for brain health services—part 4 of 6. Alzheimer’s Res Ther. 2021;13(1):171. doi: 10.1186/s13195-021-00875-8
   PubMed Web of Science ®Google Scholar
• Akpa OM, Okekunle AP, Asowata OJ, et al. Frequent vegetable consumption is inversely associated with hypertension among indigenous Africans. Eur J Prev Cardiol. 2022;29(18):2359–2371. doi: 10.1093/eurjpc/zwac208
   PubMed Web of Science ®Google Scholar
• Okekunle AP, Asowata O, Akpa OM, et al. Dietary patterns associated with stroke among West Africans: a case–control study. Int J Stroke. 2023;18(2):193–200. doi: 10.1177/17474930221094933
   PubMed Web of Science ®Google Scholar
• Ding H, Reiss AB, Pinkhasov A, et al. Plants, plants, and more plants: plant-derived Nutrients and their protective roles in cognitive function, Alzheimer’s disease, and other dementias. Medicina (Kaunas). 2022;58(8):1025. doi: 10.3390/medicina58081025
   PubMed Web of Science ®Google Scholar
• Godos J, Grosso G, Ferri R, et al. Mediterranean diet, mental health, cognitive status, quality of life, and successful aging in southern Italian older adults. Exp Gerontol. 2023;175:112143. doi: 10.1016/j.exger.2023.112143
   PubMed Web of Science ®Google Scholar
• Saito S, Yamamoto Y, Ihara M. Development of a multicomponent intervention to prevent Alzheimer’s disease. Front Neurol. 2019;10:490. doi:10.3389/fneur.2019.00490
   PubMed Web of Science ®Google Scholar
• Currenti W, Godos J, Alanazi AM, et al. Dietary fats and cognitive status in Italian middle-old adults. Nutrients. 2023;15(6):1429. doi: 10.3390/nu15061429
   PubMed Web of Science ®Google Scholar
• Fisicaro F, Lanza G, Pennisi M, et al. Daily mocha coffee intake and psycho-cognitive status in non-demented non-smokers subjects with subcortical ischaemic vascular disease. Int J Food Sci Nutr. 2022;73(6):821–828. doi: 10.1080/09637486.2022.2050999
   PubMed Web of Science ®Google Scholar
• Fisicaro F, Lanza G, Pennisi M, et al. Moderate mocha coffee consumption is associated with higher cognitive and mood status in a non-demented elderly population with subcortical ischemic vascular disease. Nutrients. 2021;13(2):536. doi: 10.3390/nu13020536
   PubMed Web of Science ®Google Scholar
• Sekikawa A, Higashiyama A, Lopresti BJ, et al. Associations of equol-producing status with white matter lesion and amyloid-β deposition in cognitively normal elderly Japanese. Alzheimers Dement (N Y). 2020;6(1):e12089. doi: 10.1002/trc2.12089
   PubMedGoogle Scholar
• Hess NC, Smart NA. Isometric exercise training for managing vascular risk factors in mild cognitive impairment and Alzheimer’s disease. Front Aging Neurosci. 2017;9:48. doi:10.3389/fnagi.2017.00048
   PubMed Web of Science ®Google Scholar
• Barnes JN, Pearson AG, Corkery AT, et al. Exercise, arterial stiffness, and cerebral vascular function: potential impact on brain health. J Int Neuropsychol Soc. 2021;27(8):761–775. doi:10.1017/S1355617721000394
   PubMed Web of Science ®Google Scholar
• Stevenson W, Hase Y, Wilson E, et al. Long-term effects of experimental carotid stenosis on hippocampal infarct pathology, neurons and glia and amelioration by environmental enrichment. Brain Res Bull. 2020;163:72–83. doi: 10.1016/j.brainresbull.2020.07.014
   PubMed Web of Science ®Google Scholar
• Hase Y, Polvikoski TM, Ihara M, et al. Carotid artery disease in post-stroke survivors and effects of enriched environment on stroke pathology in a mouse model of carotid artery stenosis. Neuropathol Appl Neurobiol. 2019;45(7):681–697. doi: 10.1111/nan.12550
   PubMed Web of Science ®Google Scholar
• LaCroix AZ, Hubbard RA, Gray SL, et al. Trajectories of physical function prior to death and brain neuropathology in a community-based cohort: the act study. BMC Geriatr. 2017;17(1):258. doi: 10.1186/s12877-017-0637-7
   PubMedGoogle Scholar
• Frisoni GB, Altomare D, Ribaldi F, et al. Dementia prevention in memory clinics: recommendations from the European task force for brain health services. Lancet Reg Health Eur. 2023;26:100576. doi: 10.1016/j.lanepe.2022.100576
   PubMedGoogle Scholar
• Shannon OM, Lee V, Bundy R, et al. Feasibility and acceptability of a multi-domain intervention to increase Mediterranean diet adherence and physical activity in older UK adults at risk of dementia: protocol for the MedEx-UK randomised controlled trial. BMJ Open. 2021;11(2):e042823. doi: 10.1136/bmjopen-2020-042823
   PubMed Web of Science ®Google Scholar
• Cantone M, Lanza G, Fisicaro F, et al. Evaluation and treatment of vascular cognitive impairment by transcranial magnetic stimulation. Neural Plast. 2020;2020:8820881. doi: 10.1155/2020/8820881
   PubMed Web of Science ®Google Scholar
• Lanza G, Bella R, Giuffrida S, et al. Preserved transcallosal inhibition to transcranial magnetic stimulation in nondemented elderly patients with leukoaraiosis. Bio Med Res Int. 2013;2013:351680. doi: 10.1155/2013/351680
   Google Scholar
• Balasubramanian P, DelFavero J, Ungvari A, et al. Time-restricted feeding (TRF) for prevention of age-related vascular cognitive impairment and dementia. Ageing Res Rev. 2020;64:101189. doi: 10.1016/j.arr.2020.101189
   PubMed Web of Science ®Google Scholar
• Forte M, Rodolico D, Ameri P, et al. Molecular mechanisms underlying the beneficial effects of exercise and dietary interventions in the prevention of cardiometabolic diseases. J Cardiovasc Med (Hagerstown). 2023;24(Supplement 1):e3–e14. doi: 10.2459/JCM.0000000000001397
   PubMedGoogle Scholar
• Kalaria RN, Maestre GE, Arizaga R, et al. Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008;7(9):812–826. doi: 10.1016/S1474-4422(08)70169-8
   PubMed Web of Science ®Google Scholar
• O’Donnell MJ, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761–775. doi: 10.1016/S0140-6736(16)30506-2
   PubMed Web of Science ®Google Scholar
• Owolabi MO, Sarfo F, Akinyemi R, et al. Dominant modifiable risk factors for stroke in Ghana and Nigeria (SIREN): a case-control study. Lancet Glob Health. 2018;6(4):e436–e446. doi: 10.1016/S2214-109X(18)30002-0
   PubMed Web of Science ®Google Scholar
• Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395(10226):795–808. doi: 10.1016/S0140-6736(19)32008-2
   PubMed Web of Science ®Google Scholar
• Schwarzinger M, Pollock BG, Hasan OSM, et al. Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study. Lancet Public Health. 2018;3(3):e124–e132. doi:10.1016/S2468-2667(18)30022-7
   PubMed Web of Science ®Google Scholar
• Price BR, Wilcock DM, Weekman EM. Hyperhomocysteinemia as a risk factor for vascular contributions to cognitive impairment and dementia. Front Aging Neurosci. 2018;10:350. doi:10.3389/fnagi.2018.00350
   PubMed Web of Science ®Google Scholar
• Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413–446. doi: 10.1016/S0140-6736(20)30367-6
   PubMed Web of Science ®Google Scholar
• Kivimaki M, Singh-Manoux A, Batty GD, et al. Association of alcohol-induced loss of consciousness and overall alcohol consumption with risk for dementia. JAMA Netw Open. 2020;3(9):e2016084. doi: 10.1001/jamanetworkopen.2020.16084
   PubMed Web of Science ®Google Scholar
• Piras F, Banaj N, Porcari DE, et al. Later life depression as risk factor for developing dementia: epidemiological evidence, predictive models, preventive strategies and future trends. Minerva Med. 2021;112(4):456–466. doi:10.23736/S0026-4806.21.07571-6
   PubMed Web of Science ®Google Scholar
• Huuskonen MT, Liu Q, Lamorie-Foote K, et al. Air pollution particulate matter amplifies white matter vascular pathology and demyelination caused by Hypoperfusion. Front Immunol. 2021;12:785519. doi: 10.3389/fimmu.2021.785519
   PubMed Web of Science ®Google Scholar
• Joyce DP, Gracias CS, Murphy F, et al. Potentially undiagnosed cognitive impairment in patients with peripheral arterial disease: a systematic review of the literature. Surgeon. 2022;20(4):e134–e143. doi:10.1016/j.surge.2021.06.007
   PubMed Web of Science ®Google Scholar
• Xu YY, Xie J, Yin H, et al. The global burden of disease attributable to low physical activity and its trends from 1990 to 2019: an analysis of the global burden of disease study. Front Public Health. 2022;10:1018866. doi: 10.3389/fpubh.2022.1018866
   PubMedGoogle Scholar
• Mooldijk SS, Ikram MK, Ikram MA. Adiponectin, leptin, and Resistin and the risk of dementia. J Gerontol. 2022;77(6):1245–1249. doi:10.1093/gerona/glab267
   Google Scholar
• Wang S, Molassiotis A, Guo C, et al. Association between social integration and risk of dementia: a systematic review and meta-analysis of longitudinal studies. J American Geriatrics Society. 2023;71(2):632–645. doi:10.1111/jgs.18094
   PubMed Web of Science ®Google Scholar
• Serafin P, Zaremba M, Sulejczak D, et al. Air pollution: a silent key driver of dementia. Biomedicines. 2023;11(5):1477. doi: 10.3390/biomedicines11051477
   PubMed Web of Science ®Google Scholar
• Fu X, Eikelboom RH, Tian R, et al. The relationship of age-related hearing loss with cognitive decline and dementia in a Sinitic language-speaking adult population: a systematic review and meta-analysis. Innov Aging. 2023;7(1):igac078. doi:10.1093/geroni/igac078
   PubMed Web of Science ®Google Scholar
• Wilker EH, Osman M, Weisskopf MG. Ambient air pollution and clinical dementia: systematic review and meta-analysis. BMJ. 2023;381:e071620. doi:10.1136/bmj-2022-071620
   PubMedGoogle Scholar
• Mukadam N, Sommerlad A, Huntley J, et al. Population attributable fractions for risk factors for dementia in low-income and middle-income countries: an analysis using cross-sectional survey data. Lancet Glob Health. 2019;7(5):e596–e603. doi:10.1016/S2214-109X(19)30074-9
   PubMed Web of Science ®Google Scholar
• Mulligan MD, Murphy R, Reddin C, et al. Population attributable fraction of hypertension for dementia: global, regional, and national estimates for 186 countries. EClinicalMedicine. 2023;60:102012. doi: 10.1016/j.eclinm.2023.102012
   PubMedGoogle Scholar
• Yu JT, Xu W, Tan CC, et al. Evidence-based prevention of Alzheimer’s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. J Neurol Neurosurg Psychiatry. 2020;91(11):1201–1209. doi: 10.1136/jnnp-2019-321913
   PubMed Web of Science ®Google Scholar
• Oscanoa TJ, Amado J, Vidal X, et al. Angiotensin-receptor blockers and the risk of Alzheimer s disease: a meta-analysis. Curr Rev Clin Exp Pharmacol. 2021;16(1):73–78. doi:10.2174/1574884715666200131120224
   PubMedGoogle Scholar
• Adesuyan M, Jani YH, Alsugeir D, et al. Antihypertensive agents and incident Alzheimer’s disease: a systematic review and meta-analysis of observational studies. J Prev Alzheimers Dis. 2022;9(4):715–724. doi: 10.14283/jpad.2022.77
   PubMed Web of Science ®Google Scholar
• Battle CE, Abdul-Rahim AH, Shenkin SD, et al. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. Cochrane Database Syst Rev. 2021;2(2):CD013306. doi:10.1002/14651858.CD013306.pub2
   PubMedGoogle Scholar